Article
Genotypic resistance tests for the management of patients at simplification of highly active antiretroviral therapy.
Scandinavian journal of infectious diseases. Supplementum - 1 Jan 2003
Suter Fredy, Ghinelli Florio
Abstract excerpt
Witness for the prosecution: There is a growing interest in exploring simpler protease inhibitor (PI)-sparing regimens that could improve patients' quality of life and adherence, provide relief from adverse events and, at the same time, preserve virological and immunological success. Simplified maintenance studies have used switch regimens with equivalent antiretroviral efficacy to PI-containing highly active...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
